FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2023771057> ?p ?o ?g. }

• W2023771057 endingPage "895" @default.
• W2023771057 startingPage "882" @default.
• W2023771057 abstract "Signal transduction through the p38 mitogen-activated protein (MAP) kinase pathway is central to the transcriptional and translational control of cytokine and inflammatory mediator production. p38 MAP kinase inhibition hence constitutes a promising therapeutic strategy for treatment of chronic inflammatory diseases, based upon its potential to inhibit key pathways driving the inflammatory and destructive processes in these debilitating diseases. The present study describes the pharmacological properties of the <i>N</i>-phenyl pyridinone p38 MAP kinase inhibitor benzamide [3- [3-bromo-4-[(2,4-difluorophenyl)methoxy]-6-methyl-2- oxo-1(2<i>H</i>)-pyridinyl]-<i>N</i>,4-dimethyl-, (−)-(9CI); PH-797804]. PH-797804 is an ATP-competitive, readily reversible inhibitor of the α isoform of human p38 MAP kinase, exhibiting a <i>K</i>_i = 5.8 nM. In human monocyte and synovial fibroblast cell systems, PH-797804 blocks inflammation-induced production of cytokines and proinflammatory mediators, such as prostaglandin E₂, at concentrations that parallel inhibition of cell-associated p38 MAP kinase. After oral dosing, PH-797804 effectively inhibits acute inflammatory responses induced by systemically administered endotoxin in both rat and cynomolgus monkeys. Furthermore, PH-797804 demonstrates robust anti-inflammatory activity in chronic disease models, significantly reducing both joint inflammation and associated bone loss in streptococcal cell wall-induced arthritis in rats and mouse collagen-induced arthritis. Finally, PH-797804 reduced tumor necrosis factor-α and interleukin-6 production in clinical studies after endotoxin administration in a dose-dependent manner, paralleling inhibition of the target enzyme. Low-nanomolar biochemical enzyme inhibition potency correlated with p38 MAP kinase inhibition in human cells and in vivo studies. In addition, a direct correspondence between p38 MAP kinase inhibition and anti-inflammatory activity was observed with PH-797804, thus providing confidence in dose projections for further human studies in chronic inflammatory disease." @default.
• W2023771057 created "2016-06-24" @default.
• W2023771057 creator A5011875487 @default.
• W2023771057 creator A5039860991 @default.
• W2023771057 creator A5044557394 @default.
• W2023771057 creator A5050011479 @default.
• W2023771057 creator A5052060058 @default.
• W2023771057 creator A5057209439 @default.
• W2023771057 creator A5057242461 @default.
• W2023771057 creator A5057347507 @default.
• W2023771057 creator A5059569112 @default.
• W2023771057 creator A5065719969 @default.
• W2023771057 creator A5067784373 @default.
• W2023771057 creator A5074984769 @default.
• W2023771057 creator A5079190905 @default.
• W2023771057 creator A5080270106 @default.
• W2023771057 creator A5082983451 @default.
• W2023771057 creator A5086181250 @default.
• W2023771057 creator A5086210412 @default.
• W2023771057 date "2009-08-31" @default.
• W2023771057 modified "2023-10-15" @default.
• W2023771057 title "Anti-Inflammatory Properties of a Novel<i>N</i>-Phenyl Pyridinone Inhibitor of p38 Mitogen-Activated Protein Kinase: Preclinical-to-Clinical Translation" @default.
• W2023771057 cites W1490165777 @default.
• W2023771057 cites W1715652268 @default.
• W2023771057 cites W1829029306 @default.
• W2023771057 cites W1965059912 @default.
• W2023771057 cites W1977683934 @default.
• W2023771057 cites W1980831535 @default.
• W2023771057 cites W1985577180 @default.
• W2023771057 cites W1989729292 @default.
• W2023771057 cites W1990450424 @default.
• W2023771057 cites W2001660220 @default.
• W2023771057 cites W2016430217 @default.
• W2023771057 cites W2017011433 @default.
• W2023771057 cites W2024497842 @default.
• W2023771057 cites W2033735656 @default.
• W2023771057 cites W2042450501 @default.
• W2023771057 cites W2047217935 @default.
• W2023771057 cites W2050690958 @default.
• W2023771057 cites W2052085724 @default.
• W2023771057 cites W2059008956 @default.
• W2023771057 cites W2065213124 @default.
• W2023771057 cites W2070890242 @default.
• W2023771057 cites W2074438676 @default.
• W2023771057 cites W2075527300 @default.
• W2023771057 cites W2080963258 @default.
• W2023771057 cites W2082594472 @default.
• W2023771057 cites W2091419870 @default.
• W2023771057 cites W2100772783 @default.
• W2023771057 cites W2101460301 @default.
• W2023771057 cites W2103079623 @default.
• W2023771057 cites W2124301797 @default.
• W2023771057 cites W2129674575 @default.
• W2023771057 cites W2132049460 @default.
• W2023771057 cites W2139347911 @default.
• W2023771057 cites W2151972186 @default.
• W2023771057 cites W2155702314 @default.
• W2023771057 cites W2163122422 @default.
• W2023771057 cites W2166393142 @default.
• W2023771057 cites W4293247451 @default.
• W2023771057 doi "https://doi.org/10.1124/jpet.109.158329" @default.
• W2023771057 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/19720877" @default.
• W2023771057 hasPublicationYear "2009" @default.
• W2023771057 type Work @default.
• W2023771057 sameAs 2023771057 @default.
• W2023771057 citedByCount "55" @default.
• W2023771057 countsByYear W20237710572012 @default.
• W2023771057 countsByYear W20237710572013 @default.
• W2023771057 countsByYear W20237710572014 @default.
• W2023771057 countsByYear W20237710572015 @default.
• W2023771057 countsByYear W20237710572016 @default.
• W2023771057 countsByYear W20237710572017 @default.
• W2023771057 countsByYear W20237710572018 @default.
• W2023771057 countsByYear W20237710572019 @default.
• W2023771057 countsByYear W20237710572020 @default.
• W2023771057 countsByYear W20237710572021 @default.
• W2023771057 countsByYear W20237710572022 @default.
• W2023771057 crossrefType "journal-article" @default.
• W2023771057 hasAuthorship W2023771057A5011875487 @default.
• W2023771057 hasAuthorship W2023771057A5039860991 @default.
• W2023771057 hasAuthorship W2023771057A5044557394 @default.
• W2023771057 hasAuthorship W2023771057A5050011479 @default.
• W2023771057 hasAuthorship W2023771057A5052060058 @default.
• W2023771057 hasAuthorship W2023771057A5057209439 @default.
• W2023771057 hasAuthorship W2023771057A5057242461 @default.
• W2023771057 hasAuthorship W2023771057A5057347507 @default.
• W2023771057 hasAuthorship W2023771057A5059569112 @default.
• W2023771057 hasAuthorship W2023771057A5065719969 @default.
• W2023771057 hasAuthorship W2023771057A5067784373 @default.
• W2023771057 hasAuthorship W2023771057A5074984769 @default.
• W2023771057 hasAuthorship W2023771057A5079190905 @default.
• W2023771057 hasAuthorship W2023771057A5080270106 @default.
• W2023771057 hasAuthorship W2023771057A5082983451 @default.
• W2023771057 hasAuthorship W2023771057A5086181250 @default.
• W2023771057 hasAuthorship W2023771057A5086210412 @default.
• W2023771057 hasConcept C164027704 @default.
• W2023771057 hasConcept C17991360 @default.
• W2023771057 hasConcept C184235292 @default.

• next